Skip to site content

CRS 2022 (v22.0 and v22.1)

CRS VERSION 22.1

CRS Version 22.1 is expected to be released in July 2022.

View the CRS 2022 (v22.1) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 1.2 MB]

View the CRS 2022 (v22.1) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 767 KB]

Key enhancements included in CRS Version 22.1 are shown below.

  • Logic Changes to National GPRA/GPRAMA Report Measures 
    • GPRA Developmental Measures: 
      • Added the following GPRA Developmental topic: 
        • Screening, Brief Intervention, and Referral to Treatment (SBIRT) 
      • Removed the following GPRA Developmental topic:
        • Cancer Screening: Pap Smear Rates
      • Added measures to and removed measures from Adult Immunizations topic to align with new Pneumococcal recommendations. 
      • Updated codes and/or logic in the following measures: Weight Assessment and Counseling for Nutrition and Physical Activity; Appropriate Medication Therapy after a Heart Attack; HIV Quality of Care; Chlamydia Testing; Proportion of Days Covered by Medication Therapy; Concurrent Use of Opioids and Benzodiazepine
    • Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes: (1) Removed lower age limit for patients with ASCVD. (2) Changed lower age limit to 20 for patients with LDL greater than or equal to (>=) 190. (3) Changed the time period for the denominator exclusion of rhabdomyolysis to be during the report period. (4) Updated the statin allergy denominator exception to statin-associated muscle symptoms or an allergy. (5) Removed the denominator exception for patients with LDL less than (<) 70. (6) Updated medication taxonomy BGP PQA STATIN MEDS. 
    • Diabetes: Nephropathy Assessment: Added LOINC codes 98979-8, 98980-6 to BGP ESTIMATED GFR LOINC taxonomy. 
    • Adult Immunizations: Added CVX codes 215, 216 and CPT codes 90671, 90677 to PCV13 definition. 
    • Cancer Screening: Pap Smear Rates: (1) Changed topic name to Cervical Cancer Screening. (2) Added HPV Primary only in the past five years to the numerator. 
    • Tobacco Use and Exposure Assessment: Added POV Z71.6 and CPT G9458 to tobacco screening and tobacco user definitions. 
    • Tobacco Cessation: (1) Added POV Z71.6 and CPT G9458 to tobacco screening and tobacco cessation counseling definition. (2) Added patient education with CPT G9016 to tobacco cessation counseling definition. 
    • Statin Therapy for the Prevention and Treatment of Cardiovascular Disease: (1) Removed lower age limit for patients with ASCVD. (2) Changed lower age limit to 20 for patients with LDL greater than or equal to (>=) 190. (3) Changed the time period for the denominator exclusion of rhabdomyolysis to be during the report period. (4) Updated the statin allergy denominator exception to statin-associated muscle symptoms or an allergy. (5) Removed the denominator exception for patients with LDL less than (<) 70. (6) Updated medication taxonomy BGP PQA STATIN MEDS. 
  • Removed Dental Treatment measure from IPC report.

CRS VERSION 22.0 

CRS Version 22.0 was released on March 2, 2022. 

View the CRS 2022 (v22.0) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 754 MB]

View the CRS 2022 (v22.0) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 1 MB]

Key enhancements included in CRS Version 22.0 are shown below. 

  • Logic Changes to National GPRA/GPRAMA Report Measures
    • GPRA Developmental Measures:
      • Removed the following GPRA Developmental topics: 
        • Colorectal Cancer Screening 
        • Use of Benzodiazepine Sedative Hypnotic Medications in the Elderly 
      • Updated codes and/or logic in the following measures: Adult Immunizations; Childhood Immunizations; Cancer Screening: Pap Smear Rates; Weight Assessment and Counseling for Nutrition and Physical Activity; Physical Activity Assessment; Appropriate Medication Therapy After a Heart Attack; HIV Screening; HIV Quality of Care; Sexually Transmitted Infection (STI) Screening; Proportion of Days Covered by Medication Therapy; Concurrent Use of Opioids and Benzodiazepines 
    • Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes: (1) Added SNOMED subset PXRM BGP IPC HOSPICE to denominator exceptions. (2) Removed POV 412, I24.1, I25.2 from myocardial infarction definition. (3) Removed POV 272.0 from hypercholesterolemia definition. (4) Removed ICD-9 POVs from active liver disease definition. (5) Updated medication taxonomy BGP PQA STATIN MEDS.
    • Influenza: Added HCPCS codes Q2034-Q2039 to influenza definition.
    • Adult Immunizations: Added HCPCS codes Q2034-Q2039 to influenza definition.
    • Cancer Screening: Pap Smear Rates: Added LOINC codes 97156-4, 97157-2 to BGP HPV LOINC CODES taxonomy.
    • Colorectal Cancer Screening: Updated denominator age range to 45-75.
    • Statin Therapy for the Prevention and Treatment of Cardiovascular Disease: (1) Added SNOMED subset PXRM BGP IPC HOSPICE to denominator exceptions. (2) Removed POV 412, I24.1, I25.2 from myocardial infarction definition. (3) Removed POV 272.0 from hypercholesterolemia definition. (4) Removed ICD-9 POVs from active liver disease definition. (5) Updated medication taxonomy BGP PQA STATIN MEDS.
    • HIV Screening: Added LOINC codes 97860-1, 97861-9 to BGP HIV TEST LOINC CODES taxonomy. 
  • Removed the following topics from the Selected Measures Report: Medication Therapy for Persons with Asthma, Use of Benzodiazepine Sedative Hypnotic Medications in the Elderly 
  • Changed Baseline Year to 2016 from 2010. 
  • Updated demo patients to include those with an SSN that begins with five zeros. 

CRS 2022 DOCUMENTATION

CRS 2022 (v22.1) User Manual [PDF - 3.1 MB]

Visual CRS 2022 (v22.1) User Manual [PDF - 3.0 MB]

CRS 2022 (v22.1) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 1.2 MB]

CRS 2022 (v22.1) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 767 KB]

CRS 2022 (v22.1) Selected Measures Report Performance Measure List and Definitions [PDF - 1.1 MB]

CRS 2022 (v22.1) Elder Care Report Performance Measure List and Definitions [PDF - 736 KB]

CRS 2022 (v22.1) IPC Measures Report Performance Measure List and Definitions [PDF - 795 KB]

CRS 2022 (v22.0) User Manual [PDF - 3.2 MB]

Visual CRS 2022 (v22.0) User Manual [PDF - 2.8 MB]

CRS 2022 (v22.0) Installation Guide [PDF - 1.5 MB]

CRS 2022 (v22.0) Technical Manual [PDF - 904 KB]

CRS 2022 (v22.0) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 754 KB]

CRS 2022 (v22.0) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 1 MB]

CRS 2022 (v22.0) Selected Measures Report Performance Measure List and Definitions [PDF - 1.2 MB]

CRS 2022 (v22.0) Elder Care Report Performance Measure List and Definitions [PDF - 675 KB]

CRS 2022 (v22.0) IPC Measures Report Performance Measure List and Definitions [PDF - 775 KB]